Mutual of America Capital Management LLC Purchases 16,629 Shares of Teleflex Incorporated (NYSE:TFX)

Mutual of America Capital Management LLC increased its position in shares of Teleflex Incorporated (NYSE:TFX) by 117.7% in the fourth quarter, Holdings Channel reports. The institutional investor owned 30,757 shares of the medical technology company’s stock after buying an additional 16,629 shares during the period. Mutual of America Capital Management LLC’s holdings in Teleflex were worth $5,474,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the stock. QRG Capital Management Inc. grew its stake in Teleflex by 5.8% in the fourth quarter. QRG Capital Management Inc. now owns 2,178 shares of the medical technology company’s stock valued at $388,000 after purchasing an additional 119 shares in the last quarter. Versor Investments LP bought a new position in Teleflex in the fourth quarter valued at approximately $481,000. Proficio Capital Partners LLC bought a new position in Teleflex in the fourth quarter valued at approximately $3,297,000. Bryn Mawr Capital Management LLC bought a new position in Teleflex in the fourth quarter valued at approximately $213,000. Finally, IFP Advisors Inc grew its stake in Teleflex by 238.5% in the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company’s stock valued at $55,000 after purchasing an additional 217 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research analysts have weighed in on the company. Wells Fargo & Company decreased their price target on Teleflex from $214.00 to $146.00 and set an “equal weight” rating for the company in a research note on Friday. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. StockNews.com cut Teleflex from a “buy” rating to a “hold” rating in a research report on Friday. Piper Sandler reaffirmed a “neutral” rating and issued a $140.00 price objective (down from $255.00) on shares of Teleflex in a research report on Friday. Finally, Truist Financial cut their price objective on Teleflex from $200.00 to $149.00 and set a “hold” rating for the company in a research report on Monday. Nine research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $188.33.

Teleflex Stock Performance

NYSE:TFX opened at $135.31 on Tuesday. The stock has a market cap of $6.28 billion, a P/E ratio of 26.90, a PEG ratio of 1.73 and a beta of 1.16. The stock has a 50 day simple moving average of $174.58 and a 200 day simple moving average of $203.93. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 1-year low of $128.55 and a 1-year high of $249.90.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, topping the consensus estimate of $3.86 by $0.03. The business had revenue of $795.40 million during the quarter, compared to analysts’ expectations of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Research analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Friday, March 7th will be issued a $0.34 dividend. The ex-dividend date of this dividend is Friday, March 7th. This represents a $1.36 annualized dividend and a yield of 1.01%. Teleflex’s dividend payout ratio is presently 95.77%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.